West Pharmaceutical Services Inc
Research West Pharmaceutical Services Inc (WST) on Bullrun: valuation model: 12.7% overvalued, market cap USD 25.77B, P/E 46.8, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWST
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal12.7% overvalued
- Market capUSD 25.77B
- P/E46.8
- Dividend yield0.2%
- Financial periodQ2 2026
- RevenueUSD 872.30M
- Net incomeUSD 154.00M
- Free cash flowUSD 80.80M
- Gross margin37.7%
Valuation Snapshot
Bullrun's latest valuation model marks West Pharmaceutical Services Inc as 12.7% overvalued; latest market cap is USD 25.77B; P/E is 46.8; dividend yield is 0.2%.
Peer valuation comparison
Latest P/E is 46.79x versus a Healthcare sector median of 24.61x (90.1% above).
Latest dividend yield is 0.24% versus a Healthcare sector median of 1.84% (87.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.07B | USD 493.70M | USD 468.90M | 35.9% | 6.79 | USD 791.30M | USD 202.80M | USD 3.18B |
| FY2024 | USD 2.89B | USD 492.70M | USD 276.40M | 34.5% | 6.69 | USD 484.60M | USD 202.60M | USD 2.68B |
| FY2023 | USD 2.95B | USD 593.40M | USD 414.50M | 38.3% | 7.88 | USD 853.90M | USD 206.80M | USD 2.88B |
| FY2022 | USD 2.89B | USD 585.90M | USD 439.40M | 39.4% | 7.73 | USD 894.30M | USD 208.90M | USD 2.68B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 25.77B | 46.8 | 0.2% | 0.88 |
| 2025 | 2025-12-31 | USD 19.82B | 40.5 | 0.3% | 0.85 |
| 2024 | 2024-12-31 | USD 23.68B | 49.0 | 0.2% | 0.81 |
| 2023 | 2023-12-29 | USD 26.05B | 47.5 | 0.2% | 0.77 |
| 2022 | 2022-12-30 | USD 17.42B | 28.4 | 0.3% | 0.73 |
| 2021 | 2021-12-31 | USD 34.80B | 53.8 | 0.1% | 0.69 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.88 USD, yield 0.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.86 USD |
| FY2024 | 0.82 USD |
| FY2023 | 0.78 USD |
| FY2022 | 0.74 USD |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is West Pharmaceutical Services Inc overvalued or undervalued?
Bullrun's valuation model currently marks West Pharmaceutical Services Inc as 12.7% overvalued.
What is West Pharmaceutical Services Inc's market cap?
West Pharmaceutical Services Inc's market capitalization is USD 25.77B.
What is West Pharmaceutical Services Inc's P/E ratio?
West Pharmaceutical Services Inc's price-to-earnings (P/E) ratio is 46.8.
Does West Pharmaceutical Services Inc pay a dividend?
West Pharmaceutical Services Inc has a dividend yield of 0.2%.
What does West Pharmaceutical Services Inc do?
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.